Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $134.9500 (-0.71%) ($133.6900 - $136.1500) on Mon. Jun. 26, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.42% (three month average) | RSI | 45 | Latest Price | $134.9500(-0.71%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV declines -0.5% a day on average for past five trading days. | Weekly Trend | ABBV declines -0.2% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Normal for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(54%) SPLV(43%) DIA(39%) IBB(37%) VYM(37%) | Factors Impacting ABBV price | ABBV will decline at least -0.71% in a week (0% probabilities). VXX(-19%) EDOC(-19%) VIXM(-17%) SLV(-15%) SHY(-14%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.71% (StdDev 1.42%) | Hourly BBV | -1.2 () | Intraday Trend | -0.7% | | | |
|
Resistance Level | $136.83 | 5 Day Moving Average | $136.59(-1.2%) | 10 Day Moving Average | $136.94(-1.45%) | 20 Day Moving Average | $136.83(-1.37%) | To recent high | -18.2% | To recent low | 1.1% | Market Cap | $238.09b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |